Loading…
Loading…
EQUITY / NASDAQ · XNMS
MediciNova Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.78 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 1.78 USD · Volume 275,027
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 458,439 USD | 134,599 USD | +240.60% |
| Operating profit | -2,541,189 USD | -3,607,092 USD | — |
| Net income | -2,314,139 USD | -3,281,185 USD | — |
| Cash and cash equivalents | 25,415,921 USD | — | — |
| Total liabilities | 3,162,867 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 25,415,921 USD | — | — | 30,806,477 USD | 30,806,477 USD | 32,562,612 USD | — | — |
| Net incomeIncome statement | -2,314,139 USD | -4,900,397 USD | -2,586,258 USD | — | -11,997,957 USD | -3,050,373 USD | -9,195,678 USD | -3,281,185 USD |
| Operating profitIncome statement | -2,541,189 USD | -5,376,995 USD | — | — | -13,283,002 USD | -3,380,998 USD | -10,190,600 USD | -3,607,092 USD |
| RevenueIncome statement | 458,439 USD | 645,423 USD | — | — | 409,657 USD | 123,319 USD | 257,918 USD | 134,599 USD |
| Total assetsBalance sheet | 40,433,469 USD | — | — | 45,603,109 USD | 45,603,109 USD | 47,578,388 USD | — | — |
| Total equityBalance sheet | 37,270,602 USD | — | 39,407,234 USD | 41,586,681 USD | 41,586,681 USD | 43,964,756 USD | — | 46,856,869 USD |
| Total liabilitiesBalance sheet | 3,162,867 USD | — | — | 4,016,428 USD | 4,016,428 USD | 3,613,632 USD | — | — |
| Capital expendituresCash flow statement | — | 10,825 USD | — | — | 2,899 USD | — | 2,899 USD | — |
| Investing cash flowCash flow statement | — | -10,825 USD | — | — | -2,899 USD | — | -2,899 USD | — |
| Operating cash flowCash flow statement | — | -5,390,262 USD | — | — | -9,810,061 USD | — | -7,793,264 USD | — |
| Financing cash flowCash flow statement | — | — | — | — | 244,018 USD | — | — | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/10/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.